CUMYL-CB-MEGACLONE
CUMYL-CB-MEGACLONE (CUMYL-CBMGACLONE, SGT-273) is a gamma-carboline based synthetic cannabinoid receptor agonist that has been sold as a designer drug, first being identified in Hungary in April 2020.
Q27269991
gamma-carboline
UNK
Q19904200
synthetic cannabinoid
Concept
Q1200715
designer drug
Concept
Q104853331
CUMYL-CB-MEGACLONE
UNK
2020-04-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
April 2020
DATE
-273^^http://www.w3.org/2001/XMLSchema#decimal
-273
NUMBER
subclass of